1. Home
  2. LEXX vs GDHG Comparison

LEXX vs GDHG Comparison

Compare LEXX & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • GDHG
  • Stock Information
  • Founded
  • LEXX 2004
  • GDHG 2008
  • Country
  • LEXX Canada
  • GDHG China
  • Employees
  • LEXX N/A
  • GDHG N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • LEXX Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • LEXX 16.5M
  • GDHG 19.4M
  • IPO Year
  • LEXX N/A
  • GDHG 2023
  • Fundamental
  • Price
  • LEXX $0.82
  • GDHG $0.43
  • Analyst Decision
  • LEXX Strong Buy
  • GDHG
  • Analyst Count
  • LEXX 1
  • GDHG 0
  • Target Price
  • LEXX $4.00
  • GDHG N/A
  • AVG Volume (30 Days)
  • LEXX 200.1K
  • GDHG 1.3M
  • Earning Date
  • LEXX 07-14-2025
  • GDHG 08-19-2025
  • Dividend Yield
  • LEXX N/A
  • GDHG N/A
  • EPS Growth
  • LEXX N/A
  • GDHG N/A
  • EPS
  • LEXX N/A
  • GDHG N/A
  • Revenue
  • LEXX $615,923.00
  • GDHG $16,666,899.00
  • Revenue This Year
  • LEXX $38.85
  • GDHG N/A
  • Revenue Next Year
  • LEXX $24.13
  • GDHG N/A
  • P/E Ratio
  • LEXX N/A
  • GDHG N/A
  • Revenue Growth
  • LEXX 49.85
  • GDHG N/A
  • 52 Week Low
  • LEXX $0.78
  • GDHG $0.16
  • 52 Week High
  • LEXX $4.38
  • GDHG $174.63
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 39.23
  • GDHG 30.86
  • Support Level
  • LEXX $0.82
  • GDHG $0.16
  • Resistance Level
  • LEXX $0.86
  • GDHG $0.72
  • Average True Range (ATR)
  • LEXX 0.07
  • GDHG 0.16
  • MACD
  • LEXX -0.01
  • GDHG 0.06
  • Stochastic Oscillator
  • LEXX 15.85
  • GDHG 48.61

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: